GlassScriptPhysician profile
Shawn Gulati
NPI 1083108070
$5,212.08
in general payments reported to CMS, 2019-2025
18 companies · $542 in 2025
The $542 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $23.41 · 2021: $171 · 2022: $2,929 · 2023: $333 · 2024: $988 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,411.03 | 2022-2024 | Miebo, Xiidra |
| Abbvie INC. | $605.12 | 2023-2025 | |
| Sight Sciences, INC. | $593.75 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| New World Medical,INC. | $389.67 | 2021-2025 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Alcon Vision LLC | $269.79 | 2019-2025 | Hydrus Microstent, Rocklatan |
| Tarsus Pharmaceuticals, INC. | $264.40 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $233.11 | 2021-2024 | Idose |
| Allergan, INC. | $99.99 | 2019 | |
| Sun Pharmaceutical Industries INC. | $85.58 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $51.72 | 2019-2025 | Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $47.24 | 2019-2020 | |
| Nova Eye, INC. | $33.80 | 2023 | |
| Thea Pharma INC. | $32.76 | 2024 | Iyuzeh |
| Harrow Eye, LLC | $30.88 | 2025 | Vevye |
| Amgen INC. | $19.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.34 | 2019 | |
| Gilead Sciences, INC. | $14.85 | 2019 | |
| Carl Zeiss Meditec Cataract Technology INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Gulati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.